Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
First Chicago Venture Capital (FCVC) was the private equity and venture capital subsidiary of First Chicago Bank, which later became First Chicago NBD. During the 1980s and 1990s, it established itself as one of the most prominent and successful investment firms in the United States, with a significant focus on healthcare, life sciences, and communications. The firm was instrumental in the early development of the leveraged buyout industry and managed a diverse portfolio of high-growth companies. In 1992, a significant portion of the investment team spun off to establish Madison Dearborn Partners, now a leading global private equity firm. The remaining operations were eventually integrated into Bank One and subsequently JPMorgan Chase following a series of bank mergers. FCVC is historically recognized for its role in institutionalizing venture capital and private equity within the banking sector.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on First Chicago Venture Capital.